The global trace metal analysis market is projected to reach USD 6.9 billion by 2024 from USD 4.4 billion in 2019, at a CAGR of 9.5%. The growth of this market is mainly driven by the stringent safety and quality regulations and new international cGMP & cGDP certification for pharmaceutical excipients, increasing spending on life science R&D, advancements in technologies, growing preference to outsource analytical requirements to third-party service providers, increasing demand from applied markets, rising opportunities in emerging countries, and the need to comply with revised USP guidelines.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=83951074 Prominent players in the global trace metal analysis industry are Agilent Technologies (US), Thermo Fisher Scientific (US), PerkinElmer, Inc. (US), Analytik Jena AG (Germany), Bruker Corporation (US), Hitachi Hi-Technologies Corporation (Japan), Rigaku Corporation (Japan), Shimadzu Corporation (Japan), Eurofins Scientific (Luxembourg), Intertek Group PLC (US), SGS S.A. (Switzerland), Bureau Veritas S.A. (France), TÜV SÜD (Germany), and LGC Ltd. (UK). The trace metal analysis market in APAC is expected to grow at the highest CAGR during the forecast period. This is due to the growing use of trace metal analysis in the food industry, strategic expansion by market players in the Asia Pacific region, emerging biotech industry, increasing focus on soil testing, and the growing food safety and environmental safety concerns in several Asia Pacific countries. The increasing R&D funding, a growing number of CROs, and favorable government initiatives to promote the growth of pharmaceutical and biotechnology industries are some of the other major factors driving the growth of the Asia Pacific market. Premium Insights of Trace Metal Analysis Market: 1. Trace Metal Analysis Industry Overview 2. Asia Pacific: Trace Metal Analysis Industry, By Application and Country, 2018 3. Geographic Snapshot of the Trace Metal Analysis Industry 4. Geographic Mix: Trace Metal Analysis Industry 5. Trace Metal Analysis Industry: Developing vs Developed Markets Trace Metal Analysis Market Drivers: 1. Stringent Safety and Quality Regulations 2. Technological Advancements 3. Increasing Demand From Applied Markets 4. Rising Life Science R&D Expenditure Trace Metal Analysis Market Opportunities: 1. Growing Preference to Outsource Analytical Requirements to Third-Party Service Providers 2. Emerging Countries 3. Need to Comply With Revised USP Guidelines Agilent is the leading provider of trace metal analysis solutions across the globe. The company offers an extensive product portfolio of products and software for all the trace metal analysis technologies such as ICP-MS, ICP-OES, and AAS. The company focuses on developing technologies that enable in detecting trace metal from various samples for various industries in order to serve the customer base. Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=83951074 Thermo Fisher Scientific is a leading provider of superior quality analytical instruments, software, and services for trace metal analysis. The company continuously increases its depth of capabilities in technologies, software & services, and leverages its extensive global channels to address its customers’ emerging needs. The company focuses on R&D to maintain its leading position in this market. Also, in the past three years, Thermo Fisher Scientific launched and enhanced 15 products with innovative technologies. Applications of Trace Metal Analysis Market: 1. Environmental Testing 2. Food & Beverage Testing 3. Pharmaceutical & Biotechnology Products Testing 4. Oil & Gas Testing 5. Medical Device Testing 6. Semiconductor Testing 7. Clinical Diagnostics
0 Comments
The blood group typing market is projected to reach USD 3.12 Billion by 2021 from USD 1.95 Billion in 2016, at a CAGR of 9.8%. The increasing demand for blood and blood products, growing number of road accidents and trauma cases that necessitate blood transfusion, need for blood grouping during prenatal testing, and increasing usage of blood group typing in forensic sciences are the major factors fueling the growth of this market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=72074095 The market is segmented based on product & service, technique, test type, end user, and region. The market is segmented into four major regions North America, Europe, Asia, and the Rest of the World. In 2016, North America accounted for the largest share of the market, followed by Europe. North America will continue to dominate the market in the forecast period due to the availability of reimbursement for several surgeries and increasing prevalence of chronic disorders in the region. However, the market in Asia is expected to witness the highest CAGR, with the growth centered on China, Japan, and India. Premium Insights of Blood Group Typing Industry: 1. Blood Group Typing: Market Overview 2. Geographic Analysis: Blood Group Typing Market, By End User 3. Geographical Snapshot of the Market 4. Blood Group Typing Industry Size, By Technique, 2016 vs 2021 Key Factors Driving Growth In Blood Group Typing Market: 1. Increasing Number of Blood Donations 2. Growing Number of Road Accidents, Emergencies, and Trauma Cases Necessitating Blood Transfusions 3. Increasing Demand for Blood Group Typing in Prenatal Testing 4. Increasing Usage of Blood Group Typing in Forensic Sciences 5. Stringent Regulatory Standards for Blood Transfusion Will Fuel Market Growth Target Audience of Blood Group Typing Market: 1. Manufacturers of blood group typing products 2. Vendors and distributors of blood group typing products 3. Hospitals and clinics 4. Blood banks 5. Research institutes 6. Venture capitalists and investors Blood Group Typing Market, by Product & Service: 1. Consumables 2. Instruments 3. Services Blood Group Typing Market, by Technique 1. PCR-based and Microarray Techniques 2. Assay-based Techniques 3. Massively Parallel Sequencing Techniques 4. Other Techniques Blood Group Typing Market, by Test Type 1. Antibody Screening 2. HLA Typing 3. Cross-matching Tests 4. ABO Blood Tests 5. Antigen Typing Key players in the Blood Group Typing Market include Bio-Rad Laboratories, Inc. (U.S.), Grifols, S.A. (Spain), Immucor, Inc. (U.S.), Ortho Clinical Diagnostics, Inc. (U.S.), Quotient, Ltd. (U.S.), Novacyt Group (France), BAG Healthcare GmbH (Germany), Rapid Labs (U.K.), Day medical SA (Switzerland), DIAGAST (France), and AXO Science (France). Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=72074095 Bio-Rad Laboratories, Inc. was the largest player in the market in 2015 with its strong product portfolio for blood group typing. The company focuses on acquisitions to strengthen its position in the market. For instance, in February 2015, Bio-Rad Laboratories acquired GnuBIO Inc. (U.S.). This acquisition helped the company to expand its blood group typing portfolio. Such acquisitions enabled the company to increase its product portfolio in the market. The company is also focused on expansion activities to increase its global presence. The key strategies followed by most companies in the market are product launches and acquisitions. Phototherapy Equipment | Emerging Innovations and New Technologies Indicates Impressive Growth Rate10/23/2019 What are the Global Growth Factors of Phototherapy Equipment Market?
A number of factors, such as the rising incidence of neonatal jaundice across developed and developing markets, rising number of people suffering from skin diseases, inflow of technologically advanced products, and rising adoption of LED-based phototherapy equipment are driving the growth of Phototherapy Equipment Market. What The Experts Says about the Market Growth? The market is expected to reach $583.4 Million by 2021, at a CAGR of 4.5% from 2016 to 2021. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174360683 Browse and in-depth TOC on "Phototherapy Equipment Market" 63 – Tables 41 - Figures 119 - Pages Based on the type of equipment, the global phototherapy equipment market is divided into three segments, namely, conventional phototherapy equipment, LED phototherapy equipment, and fiberoptic phototherapy equipment. Based on the type of lamp installed in conventional phototherapy equipment, they are further segmented into equipment with fluorescent lamps and equipment with compact fluorescent lamps. Conventional phototherapy equipment with fluorescent lamps come in two different sizes, namely, full body phototherapy equipment and partial body phototherapy equipment. On the basis of applications, the global phototherapy equipment market is segmented into skin disease treatment and neonatal jaundice treatment. The skin disease treatment segment is further divided into psoriasis treatment, vitiligo treatment, eczema treatment, and other disease treatment. On the basis of end user, the global phototherapy equipment industry is segmented into hospitals & clinics and home users. Geographical Analysis: North America held the largest share of the global phototherapy equipment market, followed by Europe. However, the Asia-Pacific market is expected to register the highest CAGR of 6.1% from 2016 to 2021. Factors such as strategic expansions by key market players in emerging Asian countries; growing adoption of low cost phototherapy equipment in India and China; and rising number of people suffering from skin diseases are responsible for the growth of the phototherapy equipment market in the Asia-Pacific region. Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=174360683 Key Market Players: GE Healthcare (U.K.), Philips Lighting Holding B.V. (Netherlands), Natus Medical Incorporated (U.S.), Phoenix Medical Systems Pvt. Ltd. (India), Herbert Waldmann GmbH & Co. KG (Germany), Atom Medical Corporation (Japan), nice Neotech Medical Systems Pvt. Ltd. (India), National Biological Corp. (U.S.), and Solarc Systems Inc. (Canada) are some of the key players operating in the global phototherapy equipment market. GE is one of the key global manufacturers of phototherapy equipment products. It sells its phototherapy equipment under the fetal and neonatal care segment. In order to sustain its leadership and ensure its future growth, the company has focused on both organic (new product launches and expansion) and inorganic growth strategies (such as collaboration and agreements). By pursuing collaboration and agreements, the company has increased its customer base and sales & distribution networks across major markets. For example, in 2013, GE Healthcare signed an agreement with HealthTrust (U.S.) and collaborated with Perkumpulan Obstetri dan Ginekologi Indonesia (POGI, Indonesia). Furthermore, the company also focuses on strengthening its market presence in high-growth regions such as in Asia and Africa to compensate for revenue losses incurred in developed markets (such as the U.S. and Europe) What is the future growth analysis of global Downstream Processing Market?
The global downstream processing market is poised to reach USD 22.03 Billion by 2021 from USD 10.32 Billion in 2016, at a CAGR of 16.4% What are key factors driving growth of global Downstream Processing Market? The growth of this market is propelled by the increasing demand for biopharmaceuticals and increasing R&D expenditure in the biopharmaceutical industry. Emerging markets such as Asia-Pacific provide new growth opportunities to players in the market. What the growth opportunities are in Downstream Processing Market? 1. Untapped Emerging Markets 2. Patent Expiry Know more, Download PDF Brochure Now: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=73180930 Global Market Segmentation: In the current market scenario, there is a growing demand for downstream processing. The market has been categorized based on the technique, product, application, end user, and region. On the basis of product, the downstream processing market is classified into chromatography columns and resins, filters, membrane adsorbers, single-use products, and other products. In 2016, the chromatography columns and resins segment accounted for the largest share of the market. The constant need for newer and different types of columns and resins is likely to fuel market growth. Based on technique, the market is segmented into purification, solid-liquid separation, and clarification/concentration. In 2016, the purification segment accounted for the largest share of the market. This high growth is attributed to the need for highly pure biopharmaceutical products to meet the regulatory standards, as downstream purification plays a significant role in enhancing the purity and quality of products aiding the growth of the purification market. Based on application, the downstream processing market is categorized into monoclonal antibody (mAbs) production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and other applications. In 2016, the vaccine production segment accounted for the largest share of the market. Technological advancement in the downstream purification technology to develop high-quality products such as Vaccines at lower costs is expected to drive the growth of this segment. Based on end user, the market is segmented into biopharmaceutical manufacturers and contract manufacturing organizations (CMOs). In 2016, the biopharmaceutical manufacturers segment accounted for the largest share of the market. The increasing demand for biopharmaceuticals among the aging population is expected to accelerate the growth of the biopharmaceutical manufacturers’ end-user segment. Geographic Growth Analysis: The growth of this market is propelled by the increasing demand for biopharmaceuticals and increasing R&D expenditure in the biopharmaceutical industry. Emerging markets such as Asia-Pacific provide new growth opportunities to players in the market. On the other hand, the high cost of instruments and the need for skilled professionals are expected to restrain the growth of this market to a certain extent during the forecast period. In addition, purification bottleneck, lack of single-use options, and dearth of skilled professionals are the major challenges in the downstream processing market Get Your Queries Resolved From Subject Expert | Speak To Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=73180930 Key Players In Global Downstream Processing Market: The market is dominated by established players such as Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), and Danaher Corporation (U.S.). What are the Global Growth Factors?
Growth in the point of care molecular diagnostics market is mainly driven by factors such as the increasing worldwide prevalence of infectious diseases, rising focus on decentralized diagnostics, and the growing demand for CLIA-waived molecular POC tests. What The Experts Says about the Market Growth? The global point of care molecular diagnostics market is expected to reach USD 1440.2 Million by 2023 from USD 725.5 Million in 2018, at a CAGR of 14.7%. Browse and in-depth TOC on "Point of Care Molecular Diagnostics Market" 68 – Tables 23 – Figures 106 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143524127 Global Market Segmentation: On the basis of product & service, the market is broadly segmented into assays & kits, instruments/analyzers, software & services. The assays & kits segment is expected to hold the largest share of the market in 2018 and is also projected to grow at highest CAGR in the global POC molecular diagnostics market during the forecast period. On the basis of technology, the market is broadly segmented into RT-PCR, INAAT, and other technologies. The RT-PCR segment is expected to account for the largest share of the global POC molecular diagnostics market in 2018. RT-PCR is a highly cost-effective and preferred technology for POC settings that allows for the concurrent monitoring of expression levels of multiple genetic messages. Such benefits are driving the growth of the RT PCR segment. On the basis application, the market is broadly segmented into respiratory diseases, hospital-acquired infections (HAIs), sexually transmitted diseases (STDs), oncology, hepatitis, and other applications (meningococcal meningitis, malaria, herpes simplex virus, Ebola, Zika virus). On the basis of end users, the market is broadly segmented into physician offices, hospital EDs and ICUs, research institutes, and other end users. The physician offices segment is expected to hold the largest share of the market. Geographical Analysis of Point of Care Molecular Diagnostics Market: North America is expected to account for the largest share of the global POC molecular diagnostics market. The growing prevalence of infectious diseases, increasing number of CLIA product approvals, and rising government initiatives to support the adoption of POC molecular diagnostics in this region are driving the market growth. Get Your Queries Resolved From Subject Expert | Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=143524127 Key Market Players: Some of the key players in the global POC molecular diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Biomerieux SA (France), and Danaher (US). Product development was the major strategy adopted by these major players to maintain their leadership position in the global POC molecular diagnostics market. Bio Decontamination | An Emerging Market will Revolutionize the Global Healthcare Industry10/4/2019 What is the future growth analysis of global Bio Decontamination Market?
The bio decontamination market is projected to reach USD 175 million by 2024 from USD 130 million in 2019, at a CAGR of 6.1% What are key factors driving growth of global Bio Decontamination Market? The rising incidence of hospital-acquired infections (HAIs), growth in the pharmaceutical and biotechnology industries, and increasing outsourcing of bio decontamination services are factors driving the growth of the bio decontamination market. What the growth opportunities are in Bio Decontamination Market? 1. Untapped Emerging Markets 2. Growth in the Pharmaceutical and Biotechnology Industries Know more, Download PDF Brochure Now: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=104696777 Global Market Segmentation: In the current market scenario, there is a growing demand for bio decontamination. The market has been categorized based on the product, type, end user and region. On the basis of product & service, the bio decontamination market is segmented into equipment, consumables, and services. In 2018, the equipment segment accounted for the largest market share of bio decontamination industry. The launch of new and advanced instruments, portability, and the reduced need for manual intervention are key factors driving the growth of this segment. By type, the bio decontamination industry is segmented into room and chamber bio decontamination. In 2018, chambers accounted for the largest share of the market. The large share of this segment can be attributed to factors such as lower power consumption, smaller footprint, and cost-effectiveness. On the basis of agent type, the bio decontamination market is segmented into hydrogen peroxide, nitrogen dioxide, chlorine dioxide, and peracetic acid. In 2018, the hydrogen peroxide segment accounted for the largest share of the bio decontamination industry. The advantages offered by hydrogen peroxide, such as material compatibility and safety with minimum residue, are the major factors contributing to its dominance in the bio decontamination industry. On the basis of end user, the biodecontamination market is segmented into pharmaceutical & medical device manufacturing companies, hospitals & healthcare facilities, and life sciences & biotechnology research organizations. In 2018, the pharmaceutical & medical device manufacturing companies segment accounted for the largest market share and highest growth rate, owing to the growing adoption of biodecontamination products & services by pharmaceutical and medical device manufacturing industries to adhere to stringent regulations. Geographic Growth Analysis: On the basis of region, the bio decontamination market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2018, North America commanded the largest share of the bio decontamination industry. The large share of this regional segment can be attributed to the growing demand for bio decontamination technologies from the healthcare industry to minimize the occurrence of hospital-acquired infections and the presence of major players in the region. Get Your Queries Resolved From Subject Expert | Speak To Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=104696777 Key Players In Global Bio Decontamination Market: The major players operating in this market are STERIS (US), Ecolab, Inc. (US), TOMI Environmental Solutions, Inc (US), JCE Biotechnology (France), Fedegari Autoclavi SpA (Italy), Zhejiang Tailin Bioengineering Co., Ltd. (China), Noxilizer, Inc. (US), Howorth Air Technology Limited (UK), Wenzhou Weike Biological Laboratory Equipment Co., Ltd. (China), ClorDiSys Solutions Inc. (US), and Amira S.r.l. (Italy). The NGS-based RNA-sequencing market size is projected to reach USD 4.2 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 20.0%. An increasing number of RNA-seq grants, advantages of RNA-seq over conventional technologies, rapid growth in precision medicine market clubbed with a growing number of research activities involving RNA-seq are the key factors driving the growth of the NGS-based RNA-sequencing industry.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102977816 Based on product & service, the market is segmented into sample preparation products, RNA sequencing platforms & consumables, RNA sequencing services, and data analysis, storage, and management. In 2018, the RNA sequencing platforms & consumables segment accounted for the largest share of the NGS-based RNA-sequencing market. This can be attributed to the ongoing technological advancements in the market and the increasing availability of innovative & cost-effective sequencing platforms. Based on technology, the NGS-based RNA-sequencing industry is segmented into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing. In 2018, the largest NGS-based RNA-sequencing market share was held by the sequencing by synthesis segment. The large share of this segment is attributed to the development of new and advanced NGS platforms and the increasing demand for Illumina’s systems, as it is the major provider of NGS platforms that use the SBS technology. By region, the NGS-based RNA-sequencing industry is segmented into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa. The market in Asia Pacific is projected to register the highest CAGR during the forecast period. Significant focus on R&D activities as a means of broadening the scope of RNA-Seq applications and decreasing the costs of NGS products and services are some of the key factors supporting the growth of the NGS-based RNA-sequencing market in the Asia Pacific. What is the Future Growth Analysis of Physiotherapy Equipment Market?
The physiotherapy equipment market is projected to reach USD 21.1 billion by 2024 from US 15.0 billion in 2018, at a CAGR of 5.8%. What are the Key Factors Driving Growth in Physiotherapy Equipment Market? The growth of this market is primarily driven by rapidly growing geriatric population and the subsequent increase in the global prevalence of chronic diseases, and growing incidence of sports injuries, degenerative joint disorders, and cerebrovascular disease. What are the latest Opportunities and Challenges in the Global Physiotherapy Equipment Market? Opportunities: 1. Emerging Markets 2. Technological Advances Challenges: 1. Shortage of Skilled Personnel 2. Alternative therapies Such as Acupuncture Know more, Download PDF Brochure Now: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65250228 Global Market Segmentation: In the current market scenario, there is a growing demand for physiotherapy equipment. The market has been categorized based on product, application and region. The electrotherapy equipment segment is projected to hold the largest share of the market, during the forecast period. The large share of the segment is primarily attributed to the by rapid adoption electrical stimulation-based techniques in rehabilitation. Transcutaneous Electrical Nerve Stimulation, Functional Neuromuscular Stimulation, H-wave Stimulation, Neuromuscular Electrical Stimulation, Interferential Stimulation, Microcurrent Stimulation, Galvanic Stimulation, Sympathetic Therapy, Peripheral Subcutaneous Field Stimulation, Peroneal Nerve Stimulation, and Auricular Stimulation (P-stim). On the basis of application, the market is segmented into cardiovascular and pulmonary applications, musculoskeletal applications, neurological applications, pediatric applications, gynecological applications, and other applications (includes sports and palliative care). In 2018, the musculoskeletal applications segment accounted for the largest share of the market, followed by the neurological applications segment. The large share of the musculoskeletal applications segment is attributed to the rising incidence of musculoskeletal disorders, growth in the geriatric population, and the increasing number of accidents. Geographical Growth Analysis Of Global Physiotherapy Equipment Market: The physiotherapy equipment market is predominantly divided into four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World. Europe accounted for the largest share of this market, followed by North America. The major drivers for the growth of this market are the rising geriatric population, increasing inclination for active lifestyles, the penetration of physiotherapy services, and favorable healthcare reforms. However, an uncertain reimbursement scenario and the need for reforms in physiotherapy educational practices are hindering the growth of this market. Key Market Players: Major vendors in the physiotherapy equipment market include DJO Global (US), Performance Health (US), BTL Industries (US), and EMS Physio (UK). Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=65250228 What are the Recent Developments in The Physiotherapy Equipment Market? 1. In 2018, DJO entered into a strategic partnership with XPO Logistics, to manage portions of DJO’s North American distribution operations. 2. In 2017, Dynatronics partnered with Orthopedic Outfitters to distribute Dynatronics’ physiotherapy and rehabilitation products. Key Information Addressed in Research Study: 1. Who are the major market players in the physiotherapy equipment and accessories market? 2. What are the growth trends and the largest revenue-generating region for physiotherapy equipment? 3. How are physiotherapy equipment sold to customers? 4. What are the major types of physiotherapy equipment and accessories? 5. What are the driving, restraining, opportunistic, and challenging factors for this market? Emerging Innovations in Biosurgery Products Indicates Impressive Growth in Biosurgery Market9/22/2019 Biosurgery Market:
The overall biosurgery market is expected to grow from $10.67 billion in 2017 and is expected to grow at a CAGR of 6.5% during the forecast period, to reach $15.58 billion by 2023. What are the key market growth factors? 1. Rising geriatric population 2. Increasing volume of surgeries and prevalence of severe trauma injuries 3. Strong focus on R&D leading to the launch of new and advanced products 4. Rising need for effective blood loss management in patients The biosurgery market is expanding with the emergence of new products and applications. These biosurgery product being used in many applications such gynecological surgery, general surgery, orthopedic surgery, cardiovascular surgery, neurological surgery, urological surgery, reconstructive surgery and thoracic surgery. Increasing Use of Biosurgery Products in Surgical Producers: Biosurgery products are used to aid surgeries and repair weakened and damaged tissues and bones. Some commonly used biosurgery products include Surgical Sealants and adhesives, hemostatic agents, adhesion barriers, soft-tissue attachments, bone-graft substitutes, and staple line reinforcement agents. These products are intended to control blood loss, aid wound healing, and assist the healing of surgical sites during various surgeries. Therefore, the rising geriatric population, increase in the volume of surgeries and sports-related and trauma injuries, increasing clearance of biosurgery products by regulatory authorities, and growing need for effective blood loss management in patients drives the growth of market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166922302 Application of Biosurgery Market: Orthopedic surgeries is one of those applications where the procedures are associated with significant blood loss owing to the dissection of bony and fibrotic tissues. Gynecological procedures such as myomectomies (surgical removal of uterine fibroids without the removal of the uterus), hysterectomies (surgical removal of the uterus), and surgeries for C-section requires biosurgery products. Biosurgery products are used in surgical procedures performed for the treatment of diseases involving the skin, soft tissues, and hernias. Of these, hernia repair, for inguinal, umbilical, hiatal, femoral, and incisional hernias, among other types, are among the most common. Biosurgery products for cardiovascular surgeries include coronary artery bypass grafting (CABG), congenital heart surgery, aortic anastomosis during CABG, and implantation of vascular prostheses. Technological Innovations in Biosurgery Products Opening New Avenues For Growth In Biosurgery Market. Target Audience: 1. Biosurgery product manufacturers 2. Biosurgery product distributors and suppliers 3. Healthcare providers 4. Medical device manufacturers 5. Research institutes and academic centers 6. Contract research organizations (CROs) 7. Government associations 8. Market research and consulting firms 9. Venture capitalists and investors Key Players in Market: The biosurgery market comprises a network of players involved in the research and product development; raw material supply; component manufacturing; distribution and sale; and post-sales services. Key players considered in the analysis of the market are Baxter International (US), C.R. Bard (US), Johnson & Johnson (US), Medtronic (Ireland), Sanofi (France), B. Braun (Germany), MAQUET Holding (Germany), CryoLife (US), Stryker Corporation (US), Hemostasis (US), Integra Lifesciences (US), Cohera Medical (US), Pfizer (US), and CSL Limited (Australia). Major Developments In Biosurgery Market: 1. Integra LifeSciences Holdings Corporation (US) launched the Codman Specialty Surgical product portfolio in April 2018. 2. Baxter International Inc. (US) enhanced its FLOSEAL and TISSEEL hemostatic product OFFERINGS in April 2017. 3. In September 2017, Medtronic launched the Infuse Bone Graft, which is a recombinant human bone morphogenetic protein-2 (rhBMP-2) applied to an absorbable collagen sponge carrier (ACS). It helps stimulate natural bone formation. Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=166922302 The global plasma therapy market comprises various types of platelet-rich plasma that are used by hospitals & clinics and several research institutions.
What are the Global Growth Factors? Rise in the number of orthopedic disorders associated with trauma and aging led to the increased demand for minimally-invasive therapies. This has further contributed to the increased demand for PRP in orthopedic, dermatology, nerve injury, cardiac muscle injury, and dental applications. What is the future analysis of Plasma Therapy Market? The global plasma therapy market is expected to grow from USD 135.6 Million in 2016 to USD 297.6 Million by 2021, at a CAGR of 14.0% from 2016 to 2021. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186196333 Global Market Segmentation: The global market is segmented on the basis of type, source, application, end user, and region. On the basis of type, the plasma therapy market is segmented into pure PRP, leucocyte-rich PRP, platelet-rich fibrin (PRF), and leukocyte-rich fibrin (L-PRF). The pure PRP segment is estimated to account for the largest share of the global market in 2016. One of the most significant factors driving the growth of this market includes the effective results of pure PRP therapy. However, lack of reimbursement policies and varying prices of plasma therapy are hindering the growth of the market. On the basis of source, the market is segmented into autologous and allogenic. The autologous segment is estimated to account for the largest share of the global market in 2016. Awareness of plasma therapy and its acceptance as a suitable remedy for healing of bones and other tissues are driving the growth of the autologous source segment of the market. Based on application, the plasma therapy market is segmented into orthopedics, dermatology, dental, cardiac muscle injury, nerve injury, and others. The orthopedic segment is further segmented into arthritis, chronic tendinitis, and bone repair & regeneration. Similarly, the dermatology segment is further segmented into androgenic alopecia and plastic surgery. The dermatology segment is expected to grow at the highest CAGR from 2016 to 2021, owing to the increasing number of dermatological disorders. On the basis of end user, the market is classified into hospitals & clinics and research institutions. The hospitals & clinics segment is estimated to account for the largest share of the global market in 2016. This large share is mainly attributed to rise in healthcare expenditure and increase in the use of PRP products in hospitals. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=186196333 Geographical Analysis: Geographically, the market is led by North America, followed by Europe, Asia-Pacific, and rest of the world (RoW). Growth in the global market is primarily driven by the increase in aging population and rise in the number of orthopedic disorders. Target Audience of Plasma Therapy Market: 1. Platelet-rich Plasma (PRP) Manufacturers and Suppliers 2. Academic Research Institutes 3. Hospitals & Clinics 4. Research & Development (R&D) Companies 5. Business Research & Consulting Service Providers 6. Medical Research Laboratories 7. Academic Medical Centers & Universities Key Players: Major players operating in Plasma Therapy Market include BioLife Plasma Services (U.S.), Cambryn Biologics LLC (U.S.), Biotest (Germany), CSL Ltd. (Australia), Grifols International S.A. (Spain), Kedrion S.p.A. (Italy), LFB (France), Bio Products Laboratory Ltd. (U.K.), China Biologic Products, Inc. (China), and Octapharma (Switzerland). |
AuthorHere you will find the latest and updated market research, new trends of global Healthcare Industry |